In the tumor environment, ECs are capable of expressing and using components of the RAAS signaling pathway to promote tumor growth, enhance angiogenesis and promote metastasis by providing components such as VEGF, a pro-angiogenic agent, and adhesion molecules such as VCAM1. The gene discussed is VCAM1; the disease is neoplasm.